ProBeam 360°

Next-generation proton therapy with a smaller footprint.

  • 1

    Makes proton therapy more accessible

    Smaller footprint, lower cost of ownership, easier to install and ramp-up.
  • 2

    Fully-integrated

    Shares a common workflow and user interface with other market-leading products from Varian, making it easier to train and recruit staff.
  • 3

    360-degree gantry

    Deliver highly conformal plans more efficiently without the need to reposition or reimage. 15 min average door-to-door treatment time.
  • 4

    Exceptional precision

    Best-in-class imaging and high-definition pencil beam scanning to see, adapt, and deliver on target.
  • 5

    Fast treatments

    RapidScan™ technology delivers each field in <5 sec, within a single breath-hold for most patients.*
  • 6

    FLASH therapy

    FLASH is an ultra-high dose rate therapy delivered in 1 to 3 treatments. Preclinical research is being conducted using the ProBeam system in research mode.

Single-room

Delivers proton therapy without compromise, making proton therapy more accessible.

Single-room expandable

Ideal for customers who anticipate future expansion.

Multi-room

Offers the greatest flexibility for patient capacity, treatment modes, research, and total cost of ownership

Complementing ProBeam 360°

Integrate ProBeam 360 with these Varian solutions to provide more options for your patients.

ARIA Oncology-Information System

One information system for radiation, medical, and surgical oncology.

Learn more

RapidPlan

Harness the power of machine learning to improve treatment planning.

Learn more

Velocity

Transform disconnected data into actionable clinical knowledge.

Learn more

We'll help you get connected.

Our specialists can help you integrate Varian into your workflow.

If you are a current customer and need product support, please visit our Customer Support page

CE Mark and international registration pending. Not all products or features available for sale in all markets.

FLASH therapy is under preclinical research and not available for commercial sale.

*Targets